Skip to main content
Clinical Trials/NCT00926497
NCT00926497
Completed
Not Applicable

Use of Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Prospective Randomized Intervention Trial

Luzerner Kantonsspital1 site in 1 country121 target enrollmentJune 2005
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Luzerner Kantonsspital
Enrollment
121
Locations
1
Primary Endpoint
Antibiotic Treatment for More Than 72 Hours
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

Neonatal bacterial sepsis is a major cause of mortality and morbidity and early antibiotic therapy is crucial for treatment success.

Objective: To evaluate the effect of Procalcitonin-guided decision making on duration opf antibiotic therapy in suspected neonatal early-onset sepsis.

Detailed Description

This single-centre, prospective randomized intervention study was conducted in a tertiary neonatal and paediatric intensive care unit in the Children's Hospital of Lucerne, Switzerland between June 1, 2005 and December 31, 2006. All term and near term infants with suspected early-onset sepsis were randomly assigned either to standard treatment based on conventional laboratory parameters (standard group) or to Procalcitonin-guided treatment (Procalcitonin-group). Minimum duration of antibiotic therapy was (48)-72 hours in the standard group, whereas in the Procalcitonin group antibiotic therapy was discontinued when two consecutive Procalcitonin values were below predefined age-adjusted cut-off values.

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
January 2007
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Term and near-term infants with a gestational age of more than 34 weeks
  • Admitted to the Children's Hospital of Lucerne, Switzerland
  • Suspected neonatal early-onset sepsis
  • Antibiotic therapy
  • Parental consent

Exclusion Criteria

  • Surgery in the first 3 days of life
  • Severe congenital malformations
  • Chromosomal abnormalities

Outcomes

Primary Outcomes

Antibiotic Treatment for More Than 72 Hours

Time Frame: 1 month

Infants treated with antibiotics for more than 72 hours (efficacy of study intervention)

Absolute Duration of Antibiotic Therapy

Time Frame: 1 month

Co-primary endpoint was the absolute duration of antibiotic therapy(quantitative version of the primary endpoint for estimation of effect size)

Study Sites (1)

Loading locations...

Similar Trials